Physician

Richard Gary Lane, M.D.

According to 2025 Medicare claims, Richard Lane, M.D. (NPI: 1922086347) practices ophthalmology in the San Antonio-New Braunfels, TX market, with the plurality of this provider's patient population coming from Bexar, TX. This provider's primary affiliated billing organization is RETINA CONSULTANTS OF HOUSTON PLLC (NPI: 1619135647; TIN: 74-2109903) and primary practice location at 78240-1670.

Lane's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,234 traditional Medicare patients, billed 59,997 HCPCS/CPT codes, and received $5,261,466 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 633 prescription claims across 187 beneficiaries totaling $36,828 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 266 records totaling $1,044,560. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,712,759 to $5,261,466. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $19,215 and ending at $36,828. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	861	15,724	$2,712,759
2016	982	16,607	$3,364,681
2017	976	16,598	$3,313,862
2018	905	16,127	$3,274,616
2019	1,001	17,105	$3,763,803
2020	935	15,934	$3,664,085
2021	993	17,300	$3,966,438
2022	1,134	18,056	$4,484,018
2023	1,211	42,403	$4,889,493
2024	1,234	59,997	$5,261,466

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	86	228	$19,215
2016	102	290	$22,998
2017	108	340	$36,658
2018	103	298	$26,493
2019	115	333	$21,611
2020	115	359	$20,212
2021	129	373	$19,731
2022	153	539	$23,943
2023	192	666	$40,072
2024	187	633	$36,828

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92004	New patient complete exam of visual system	239	239	$106
67028	Injection of drug into eye	547	2,326	$95
92014	Established patient complete exam of visual system	658	905	$90
92134	Imaging of retina	955	2,869	$29
92250	Photography of the retina	353	393	$27

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	188	7,266	$7,553
Difluprednate	Difluprednate	45	951	$4,479
Ketorolac Tromethamine	Ketorolac Tromethamine	46	1,876	$2,126
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	75	5,935	$1,019
Tobramycin	Tobramycin	101	2,529	$503

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$2,465	EyePoint Pharmaceuticals US, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	244	$1,042,096	Bayer Healthcare Pharmaceuticals Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Richard Gary Lane, M.D.?

Tedicare shows public-source Medicare data for Richard Gary Lane, M.D. (NPI 1922086347), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard Gary Lane, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Richard Gary Lane, M.D.?

Richard Gary Lane, M.D. is linked to RETINA CONSULTANTS OF HOUSTON PLLC (billing NPI 1619135647) in the available physician profile data.

Does Richard Gary Lane, M.D. have Open Payments data?

Richard Gary Lane, M.D. has 266 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.